Pan American Health Organization   Report issue

Government Phase 2 Phase 3 Phase 4
Founded: Washington D.C. United States (1902)

Organization Overview

First Clinical Trial
1999
NCT02386358
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Alba Maria Ropero | Pan American Health Organization

Active Ingredients

Drugs in Phase 4 Trials (4)

chloroquine (2 trials)

mmr (1 trial)

primaquine (1 trial)

yellow fever vaccine 17d strain (1 trial)

Drugs in Phase 3 Trials (3)

artesunate (1 trial)

benznidazole (Rochagan) (1 trial)

mefloquine (lariam) (1 trial)

Drugs in Phase 2 Trials (1)

vaxigrip (1 trial)

Drugs in Other Trials (1)

poliovirus vaccine inactivated (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chagas Disease (Phase 3)

Influenza, Human (Phase 2)

Malaria (Phase 4)

Malaria, Falciparum (Phase 3)

Malaria, Vivax (Phase 4)

Rubella (Phase 4)

Yellow Fever (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 9